Skip to main content

Table 1 Demographic and clinical characteristics of the patients enrolled

From: Effects of hydrophilic polymer-coated polysulfone membrane dialyzers on intradialytic hypotension in diabetic hemodialysis patients (ATHRITE BP Study): a pilot study

  NV group PS/PES group P
Patients (n) 20 20  
Age (years) 62.3 ± 9.1 61.5 ± 10.1 0.78
Female (%) 7 (35%) 6 (30%) 0.74
Dialysis vintage (years) 9.2 ± 4.8 6.7 ± 4.5 0.11
Antihypertensive drug users (%) 16 (80%) 9 (45%) 0.02
Antiplatelet/anticoagulant users (%)a 14 (82%) 17 (100%) 0.23
Ejection fraction (%)a 70.4 ± 5.2 60.7 ± 8.0 < 0.01
Comorbidities
 Ischemic heart disease (%)a 7 (41%) 12 (71%) 0.17
 Heart failure (%)a 6 (35%) 5 (29%) 1.00
 Cerebral infarction (%)a 3 (18%) 2 (12%) 1.00
 Cerebral hemorrhage (%)a 0 (0%) 1 (6%) 1.00
BMI (kg/m2) 24.0 ± 5.0 24.9 ± 4.3 0.57
White blood cell count (×103/μL) 6.3 ± 1.8 6.6 ± 2.7 0.53
Hemoglobin (g/dL) 11.2 ± 0.8 11.0 ± 2.6 0.66
Platelet (×104/μL) 20.0 ± 5.2 18.5 ± 4.9 0.35
ESA user (%) 13 (65%) 10 (50%) 0.34
Ferritin (ng/mL) 122.4 ± 141.4 94.2 ± 53.8 0.41
Phosphate (mg/dL) 5.6 ± 1.5 5.4 ± 1.6 0.72
Calcium (mg/dL) 9.1 ± 0.7 8.8 ± 0.6 0.20
Intact PTH (ng/mL) 122 ± 98 162 ± 163 0.34
Albumin (g/dL) 3.5 ± 0.3 3.5 ± 0.3 0.78
Total-cholesterol (mg/dL) 171 ± 36 154 ± 28 0.10
Triglyceride (mg/dL) 124 ± 70 142 ± 86 0.49
HDL-cholesterol (mg/dL) 44 ± 14 44 ± 15 0.96
Ankle brachial index (right) 1.03 ± 0.25 1.09 ± 0.28 0.51
Ankle brachial index (left) 1.11 ± 0.19 1.12 ± 0.26 0.91
Homocysteine (nmol/mL) 35.8 ± 25.1 34.7 ± 18.5 0.87
Pentosidine (μg/mL) 0.415 ± 0.218 0.326 ± 0.108 0.11
hsCRP (mg/dL) 0.221 ± 0.174 0.187 ± 0.196 0.57
Pentraxin 3 (ng/mL) 4.04 ± 1.68 4.55 ± 3.76 0.58
Adrenaline (ng/mL) 0.02 ± 0.01 0.02 ± 0.01 0.10
Noradrenaline(ng/mL) 0.33 ± 0.19 0.38 ± 0.19 0.46
Dopamine (ng/mL) 0.04 ± 0.02 0.05 ± 0.02 0.13
  1. BMI body mass index, ESA erythropoiesis-stimulating agent, HDL high-density lipoprotein, hsCRP high-sensitivity C-reactive protein
  2. a n = 17 in both NV and PS/PES groups